180 related articles for article (PubMed ID: 23936772)
1. The association of the immune response genes to human papillomavirus-related cervical disease in a Brazilian population.
Marangon AV; Guelsin GA; Visentainer JE; Borelli SD; Watanabe MA; Consolaro ME; Caleffi-Ferracioli KR; Rudnick CC; Sell AM
Biomed Res Int; 2013; 2013():146079. PubMed ID: 23936772
[TBL] [Abstract][Full Text] [Related]
2. Significant association between IL10-1082/-819 and TNF-308 haplotypes and the susceptibility to cervical carcinogenesis in women infected by Human papillomavirus.
Chagas BS; Lima RCP; Paiva Júnior SSL; Silva RCO; Cordeiro MN; Silva Neto JDC; Batista MVA; Silva AJD; Gurgel APAD; Freitas AC
Cytokine; 2019 Jan; 113():99-104. PubMed ID: 29935877
[TBL] [Abstract][Full Text] [Related]
3. Selected class I and class II HLA alleles and haplotypes and risk of high-grade cervical intraepithelial neoplasia.
Ades S; Koushik A; Duarte-Franco E; Mansour N; Arseneau J; Provencher D; Gilbert L; Gotlieb W; Ferenczy A; Coutlée F; Roger M; Franco EL;
Int J Cancer; 2008 Jun; 122(12):2820-6. PubMed ID: 18351579
[TBL] [Abstract][Full Text] [Related]
4. Association between HLA-DRB1 polymorphism, high-risk HPV infection and cervical neoplasia in southern Chinese.
Chan PK; Cheung TH; Lin CK; Siu SS; Yim SF; Lo KW; Cheung JL; Tam AO; Tang JW
J Med Virol; 2007 Jul; 79(7):970-6. PubMed ID: 17516530
[TBL] [Abstract][Full Text] [Related]
5. Case-control study of HLA-G promoter methylation status, HPV infection and cervical neoplasia in Curitiba, Brazil: a pilot analysis.
Gillio-Tos A; Bicalho Mda G; Fiano V; Grasso C; Tarallo V; De Marco L; Trevisan M; Xavier M; Slowik R; Carvalho NS; Maestri CA; Lacerda HM; Zugna D; Richiardi L; Merletti F
BMC Cancer; 2012 Dec; 12():618. PubMed ID: 23265140
[TBL] [Abstract][Full Text] [Related]
6. Tumor necrosis factor a-11 and DR15-DQ6 (B*0602) haplotype increase the risk for cervical intraepithelial neoplasia in human papillomavirus 16 seropositive women in Northern Sweden.
Ghaderi M; Nikitina L; Peacock CS; Hjelmström P; Hallmans G; Wiklund F; Lenner P; Blackwell JM; Dillner J; Sanjeevi CB
Cancer Epidemiol Biomarkers Prev; 2000 Oct; 9(10):1067-70. PubMed ID: 11045789
[TBL] [Abstract][Full Text] [Related]
7. Tumor necrosis factor (TNF) alpha and interleukin (IL) 18 genes polymorphisms are correlated with susceptibility to HPV infection in patients with and without cervical intraepithelial lesion.
Tavares MC; de Lima Júnior SF; Coelho AV; Marques TR; de Araújo DH; Heráclio Sde A; Amorim MM; de Souza PR; Crovella S
Ann Hum Biol; 2016 May; 43(3):261-8. PubMed ID: 26079218
[TBL] [Abstract][Full Text] [Related]
8. HLA DOA1 and DOB1 loci in Honduran women with cervical dysplasia and invasive cervical carcinoma and their relationship to human papillomavirus infection.
Ferrera A; Olivo A; Alaez C; Melchers WJ; Gorodezky C
Hum Biol; 1999 Jun; 71(3):367-79. PubMed ID: 10380373
[TBL] [Abstract][Full Text] [Related]
9. An increased risk of cervical intra-epithelial neoplasia grade II-III among human papillomavirus positive patients with the HLA-DQA1*0102-DQB1*0602 haplotype: a population-based case-control study of Norwegian women.
Helland A; Olsen AO; Gjøen K; Akselsen HE; Sauer T; Magnus P; Børresen-Dale AL; Rønningen KS
Int J Cancer; 1998 Mar; 76(1):19-24. PubMed ID: 9533756
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the association of NKG2C copy number variations with susceptibility to human papillomavirus-induced cervical lesions.
Vilchez JR; Torres-Moreno D; Martínez-Senac MM; Trujillo-Santos J; Conesa-Zamora P
Hum Immunol; 2013 Oct; 74(10):1352-6. PubMed ID: 23911737
[TBL] [Abstract][Full Text] [Related]
11. Human leukocyte antigen class I and II haplotypes and risk of cervical cancer.
Carreon JD; Martin MP; Hildesheim A; Gao X; Schiffman M; Herrero R; Bratti MC; Sherman ME; Zaino RJ; Carrington M; Wang SS
Tissue Antigens; 2005 Oct; 66(4):321-4. PubMed ID: 16185329
[TBL] [Abstract][Full Text] [Related]
12. Association of human leukocyte antigen and T cell message with human papillomavirus 16-positive cervical neoplasia in Japanese women.
Saito M; Okubo M; Hirata R; Takeda S; Maeda H
Int J Gynecol Cancer; 2007; 17(6):1314-21. PubMed ID: 17433060
[TBL] [Abstract][Full Text] [Related]
13. Genetic variation in cervical preinvasive and invasive disease: a genome-wide association study.
Bowden SJ; Bodinier B; Kalliala I; Zuber V; Vuckovic D; Doulgeraki T; Whitaker MD; Wielscher M; Cartwright R; Tsilidis KK; Bennett P; Jarvelin MR; Flanagan JM; Chadeau-Hyam M; Kyrgiou M;
Lancet Oncol; 2021 Apr; 22(4):548-557. PubMed ID: 33794208
[TBL] [Abstract][Full Text] [Related]
14. Comparison of human leukocyte antigen DR-DQ disease associations found with cervical dysplasia and invasive cervical carcinoma.
Apple RJ; Becker TM; Wheeler CM; Erlich HA
J Natl Cancer Inst; 1995 Mar; 87(6):427-36. PubMed ID: 7861462
[TBL] [Abstract][Full Text] [Related]
15. Association between human leukocyte antigen class II alleles and human papillomavirus-mediated cervical cancer in Indian women.
Kohaar I; Hussain S; Thakur N; Tiwari P; Nasare V; Batra S; Singh V; Bhambani S; Das BC; Sarkar DP; Bharadwaj M
Hum Immunol; 2009 Apr; 70(4):222-9. PubMed ID: 19272325
[TBL] [Abstract][Full Text] [Related]
16. HLA class II allele control of HPV load in carcinoma in situ of the cervix uteri.
Beskow AH; Moberg M; Gyllensten UB
Int J Cancer; 2005 Nov; 117(3):510-4. PubMed ID: 15906352
[TBL] [Abstract][Full Text] [Related]
17. Susceptibility to human papillomavirus-associated cervical intra-epithelial neoplasia is determined by specific HLA DR-DQ alleles.
Odunsi K; Terry G; Ho L; Bell J; Cuzick J; Ganesan TS
Int J Cancer; 1996 Sep; 67(5):595-602. PubMed ID: 8782644
[TBL] [Abstract][Full Text] [Related]
18. Human leukocyte antigen G polymorphism is associated with an increased risk of invasive cancer of the uterine cervix.
Ferguson R; Ramanakumar AV; Koushik A; Coutlée F; Franco E; Roger M;
Int J Cancer; 2012 Aug; 131(3):E312-9. PubMed ID: 22095460
[TBL] [Abstract][Full Text] [Related]
19. Association of genomic variants at the human leukocyte antigen locus with cervical cancer risk, HPV status and gene expression levels.
Ramachandran D; Schürmann P; Mao Q; Wang Y; Bretschneider LM; Speith LM; Hülse F; Enßen J; Bousset K; Jentschke M; Böhmer G; Strauß HG; Hirchenhain C; Schmidmayr M; Tarbiat J; Runnebaum I; Dürst M; Hein A; Koch M; Ruebner M; Ekici A; Beckmann MW; Fasching PA; Luyten A; Petry KU; Hillemanns P; Dörk T
Int J Cancer; 2020 Nov; 147(9):2458-2468. PubMed ID: 32580243
[TBL] [Abstract][Full Text] [Related]
20. Single nucleotide polymorphisms in the PRDX3 and RPS19 and risk of HPV persistence and cervical precancer/cancer.
Safaeian M; Hildesheim A; Gonzalez P; Yu K; Porras C; Li Q; Rodriguez AC; Sherman ME; Schiffman M; Wacholder S; Burk R; Herrero R; Burdette L; Chanock SJ; Wang SS
PLoS One; 2012; 7(4):e33619. PubMed ID: 22496757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
